Metraipolis › archive › dc_a653de57b601
Additive Benefit of Guideline-Directed Medical Therapies at Discharge in Reducing 30-Day Readmissions in Heart Failure — Europe PMC PMID:41349147
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41349147
- DOI
- 10.1016/j.jacadv.2025.102411
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T22:42:16.042Z
- SHA-256 of the archived text
d419334112a7354a2c16364a5b7cc914a3ad6d9427140724a4652d5dc7cbbf22- Stable URL of this page
https://metraipolis.com/documento/dc_a653de57b601
How to cite
Additive Benefit of Guideline-Directed Medical Therapies at Discharge in Reducing 30-Day Readmissions in Heart Failure — Europe PMC PMID:41349147 — Europe PMC (en), https://europepmc.org/article/MED/41349147 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a653de57b601 (Metraipolis archive dc_a653de57b601, sha256 d419334112a7354a2c16364a5b7cc914a3ad6d9427140724a4652d5dc7cbbf22)
BibTeX
@misc{dca653de57b601,
title = {Additive Benefit of Guideline-Directed Medical Therapies at Discharge in Reducing 30-Day Readmissions in Heart Failure — Europe PMC PMID:41349147},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41349147},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a653de57b601; sha256 d419334112a7354a2c16364a5b7cc914a3ad6d9427140724a4652d5dc7cbbf22},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41349147. Agents can read the archived copy with the MCP tool read_document.